ALLERGAN INC 4
4 · ALLERGAN INC · Filed Mar 19, 2015
Insider Transaction Report
Form 4
ALLERGAN INCAGN
LAVIGNE LOUIS J JR
Director
Transactions
- Disposition to Issuer
Common Stock
2015-03-17−15,228→ 0 total - Disposition to Issuer
Common Stock
2015-03-17−2,920→ 0 total(indirect: By Trust)
Footnotes (3)
- [F1]Pursuant to that certain Agreement and Plan of Merger dated November 16, 2014, (the "Merger Agreement") by and among the Issuer, Actavis, Plc ("Actavis) and a wholly-owned subsidiary of Actavis, the Issuer became an indirect wholly-owned subsidiary of Actavis upon consummation of the merger (the "Effective Date"). Each share of common stock was disposed of in exchange for $129.22 cash plus 0.3683 of an Actavis ordinary share, having a market value of $_____ per share on the Effective Date.
- [F2]Shares held by the Louis Lavigne Survivor's Trust. Reporting Person is sole trustee of the Louis Lavigne Survivor's Trust.
- [F3]The number of shares reported on this line item includes shares acquired pursuant to dividend rights attached to restricted stock units that were previously granted and reported as Table 1, Non-Derivative Securities.